Fostamatinib in chronic immune thrombocytopenia: a profile of its use in the USA (vol 34, pg 451, 2018)

被引：0

作者：

McKeage, Kate ^{[1
]}

Lyseng-Williamson, Katherine A. ^{[1
]}

机构：

[1] Springer, Private Bag 65901,Mairangi Bay, Auckland 0754, New Zealand

来源：

DRUGS & THERAPY PERSPECTIVES | 2018年 / 34卷 / 12期

关键词：

D O I：

10.1007/s40267-018-0575-2

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：594 / 594

页数：1

共 50 条

[41] Tezepelumab in severe asthma: a profile of its use (Vol 39, pg 393, 2023)
Syed, Yahiya Y.
DRUGS & THERAPY PERSPECTIVES, 2024, 40 (01) : 43 - 43
[42] Efanesoctocog alfa in hemophilia A: a profile of its use (vol 40, pg 1, 2024)
Fung, Simon
Blair, Hannah A.
DRUGS & THERAPY PERSPECTIVES, 2024, 40 (03) : 138 - 138
[43] Mitotane in adrenocortical carcinoma: a profile of its use (vol 38, pg 508, 2022)
Shirley, Matt
DRUGS & THERAPY PERSPECTIVES, 2023, 39 (06) : 222 - 222
[44] Lemborexant in insomnia disorder: a profile of its use (vol 36, pg 427, 2020)
Blair, Hannah A.
DRUGS & THERAPY PERSPECTIVES, 2020, 36 (12) : 598 - 599
[45] Guselkumab in psoriatic arthritis: a profile of its use (vol 37, pg 285, 2021)
Lamb, Yvette N.
DRUGS & THERAPY PERSPECTIVES, 2021, 37 (08) : 392 - 392
[46] Single Hospital Retrospective Review of the use of Monoclonal Antibody and its Biosimilar Truxima in Chronic Immune Thrombocytopenia
Kundu, S.
Grubb, H.
BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 163 - 163
[47] A characterization of personal care product use among undergraduate female college students in South Carolina, USA (vol 87, pg 451, 2020 )
Hart, Leslie B.
Walker, Joanna
Beckingham, Barbara
Shelley, Ally
Flagg, Moriah Alten
Wischusen, Kerry
Sundstrom, Beth
JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY, 2020, 30 (05) : 900 - 900
[48] Chronic adult primary immune thrombocytopenia (ITP) in the Asia-Pacific region (vol 94, pg 142, 2011)
Lee, Lai Heng
Caguioa, Priscilla
Chin, Ng Soo
Chiou, Tzeon-Jye
Lee, Jong Wook
Miyakawa, Yoshitaka
Tambunan, Karmel L.
Chong, Beng H.
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (06) : 729 - 729
[49] Ambrisentan +/- tadalafil in WHO functional class II/III pulmonary arterial hypertension: a guide to its use in the EU (vol 34 pg 289, 2018)
Lyseng-Williamson, Katherine A.
Behr, Juergen
DRUGS & THERAPY PERSPECTIVES, 2018, 34 (10) : 496 - 496
[50] Ambrisentan ± tadalafil in WHO functional class II/III pulmonary arterial hypertension: a guide to its use in the EU (vol 34, pg 289, 2018)
Lyseng-Williamson, Katherine A.
Behr, Jurgen
DRUGS & THERAPY PERSPECTIVES, 2019, 35 (01) : 47 - 47

← 1 2 3 4 5 →